BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 6, 2022
View Archived Issues
BCY-6033: EphA2-targeting BTC with efficacy in NSCLC PDX models
Read More
Enliven Therapeutics describes new Bcr-Abl kinase inhibitors
Read More
Silverback Therapeutics synthesizes TGFR-1 inhibitors and antibody-drug conjugates
Read More
CD38 inhibitors discovered at Napa Therapeutics, Buck Institute
Read More
Kymera Therapeutics presents STAT-degrading PROTACs
Read More
Vertex Pharmaceuticals patents CFTR modulators
Read More
Platform delivers siRNA targeting VEGF intravitreally for diabetic retinopathy
Read More
Turning Point and LaNova enter license agreement for LM-302 and collaboration on ADC programs
Read More
Insilico Medicine nominates preclinical candidate targeting MAT2A for MTAP-deleted cancers
Read More
Betta Pharmaceuticals presents preclinical results for cancer candidates BPI-371153 and BPI-442096
Read More
SPH-5030 demonstrates potent and selective activity in HER2-mutant cancer models
Read More
Orion enters agreement with Jemincare for Nav1.8 blocker for treatment of pain
Read More
Mosaic signs license agreement covering use of cowpea mosaic virus to treat cancer
Read More
Preclinical pipeline progress at Intellia Therapeutics
Read More
Clover reports neutralization findings from preclinical study of bivalent COVID-19 vaccine candidate
Read More
Taking aim at tumor metabolism, while taming toxicity
Read More